|1.||Ogata, Naoshi: 2 articles (07/2008 - 01/2005)|
|2.||Kamekura, Satoru: 2 articles (07/2008 - 01/2005)|
|3.||Hoshi, Kazuto: 2 articles (07/2008 - 01/2005)|
|4.||Kawaguchi, Hiroshi: 2 articles (07/2008 - 01/2005)|
|5.||Ogasawara, Toru: 2 articles (07/2008 - 01/2005)|
|6.||Chikuda, Hirotaka: 2 articles (07/2008 - 01/2005)|
|7.||Kugimiya, Fumitaka: 2 articles (07/2008 - 01/2005)|
|8.||Ikeda, Toshiyuki: 2 articles (07/2008 - 01/2005)|
|9.||Nakamura, Kozo: 2 articles (07/2008 - 01/2005)|
|10.||Chang, Jan-Gowth: 1 article (05/2015)|
07/01/2009 - "This study suggests that the cGK II gene on chromosome 4q21 is most likely to harbour gout disease independently of hyperuricaemia and is inherited recessively."
05/01/2015 - "Cyclic GMP-dependent protein kinase II (cGKII; PRKG2) phosphorylates a variety of biological targets and has been identified as a gout-susceptible gene. "
07/01/2009 - "The cyclic GMP-dependent protein kinase II gene associates with gout disease: identified by genome-wide analysis and case-control study."
07/01/2009 - "In SNP genotyping analysis at the neighbourhood regions of marker D4S3243 for the case-control subjects, the polymorphisms rs7688672 and rs6837293, located on the cGMP-dependent protein kinase II (cGK II) gene, were found to relate significantly to gout disease in a recessive model after adjustment of hyperuricaemia (OR = 2.89, 95% CI 1.19 to 7.02 and OR = 2.72, 95% CI 1.13 to 6.54, respectively). "
01/01/2005 - "Mutation in cGMP-dependent protein kinase II causes dwarfism in a rat mutant KMI through uncoupling of proliferation and differentiation of chondrocytes."
03/01/2002 - "Dwarfism was observed in mice deficient in cGMP-dependent protein kinase II which lies downstream to cGMP. "
12/20/1996 - "Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II."
07/01/2008 - "cGMP-dependent protein kinase II (cGKII; encoded by PRKG2) is a serine/threonine kinase that is critical for skeletal growth in mammals; in mice, cGKII deficiency results in dwarfism. "
|3.||Ganglion Cysts (Ganglion)
09/01/2005 - "We used STa, cell-permeant cGMP, and cAMP agonists in conjunction with PKG and PKA inhibitors, respectively, in rat jejunum to examine whether 1) cGMP and cGK II regulate the translocation of CFTR to the apical membrane and its relevance to fluid secretion, and 2) PKA regulates cAMP-dependent translocation of CFTR because this intestinal segment is a primary target for toxigenic diarrhea. "
|1.||Messenger RNA (mRNA)
|2.||cGMP-dependent protein kinase II
|3.||Protein-Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
|4.||5'-Guanylic Acid (GMP)